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The Journal of Experimental Medicine
 
McColl et al. Vol. 198, No. 6, September 15, 2003. Pages 863–868.
Typographical errors were made in the Results section under the subheading Assay for VEGF-D Processing. In each case, kD was used instead
of the unit D, implying that the value being quoted was 1,000-fold greater than in reality. The corrected paragraph appears below:
 
A range of proteases were tested in this assay, including plasmin, thrombin, and MMP-2 and MMP-9. These
proteases were chosen because of their involvement in angiogenesis or tumor formation. MMP-2 and MMP-9
had no effect on the counts detected in the SPA, however, plasmin caused a 
 
 
 
90% reduction of signal, indicating
substantial cleavage of the peptide (Fig. 1 c). Thrombin caused a small reduction of signal. To identify the site at
which plasmin hydrolyzed the peptide, samples were analyzed by mass spectrometry. Undigested peptide consisted
of a single peak of a molecular mass of 2,282.15 D, as expected (Fig. 1 d, top). After plasmin treatment, a predom-
inant peak of a molecular mass of 1,267.68 D was observed, corresponding to Biotin-HPYSIIRR (Fig. 1 d, bot-
tom). This molecular species is an expected product of cleavage of the peptide at the same site as observed in
VEGF-D expressed in 293EBNA cells (i.e., between R205 and S206) (Fig. 1 a; reference 18). An alternative
cleavage event generating Biotin-HPYSIIR (molecular mass 1,111.59 D) was also detected.